|
1
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2020. CA Cancer J Clin. 70:7–30. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Chen Z, Fillmore CM, Hammerman PS, Kim CF
and Wong KK: Non-small-cell lung cancers: A heterogeneous set of
diseases. Nat Rev Cancer. 14:535–546. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Xia L, Zhu Y, Zhang C, Deng S, Deng Y,
Yang Z, Mei J and Liu L: Decreased expression of EFCC1 and its
prognostic value in lung adenocarcinoma. Ann Transl Med. 7:6722019.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Macheleidt IF, Dalvi PS, Lim SY, Meemboor
S, Meder L, Käsgen O, Müller M, Kleemann K, Wang L, Nurnberg P, et
al: Preclinical studies reveal that LSD1 inhibition results in
tumor growth arrest in lung adenocarcinoma independently of driver
mutations. Mol Oncol. 12:1965–1979. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Lim W, Bae H, Bazer FW and Song G: Ephrin
A1 promotes proliferation of bovine endometrial cells with abundant
expression of proliferating cell nuclear antigen and cyclin D1
changing the cell population at each stage of the cell cycle. J
Cell Physiol. 234:4864–4873. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Hydbring P, Malumbres M and Sicinski P:
Non-canonical functions of cell cycle cyclins and cyclin-dependent
kinases. Nat Rev Mol Cell Biol. 17:280–292. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Braschi B, Denny P, Gray K, Jones T, Seal
R, Tweedie S, Yates B and Bruford E: Genenames.org: The HGNC and
VGNC resources in 2019. Nucleic Acids Res. 47(D1): D786–D792. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Vishnoi N and Yao J: Single-cell,
single-mRNA analysis of Ccnb1 promoter regulation. Sci Rep.
7:20652017. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Liu D, Xu W, Ding X, Yang Y, Su B and Fei
K: Polymorphisms of CCNB1 associated with the clinical outcomes of
platinum-based chemotherapy in Chinese NSCLC patients. J Cancer.
8:3785–3794. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Wei LJ, Li JA, Bai DM and Song Y:
miR-223-RhoB signaling pathway regulates the proliferation and
apoptosis of colon adenocarcinoma. Chem Biol Interact. 289:9–14.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Li W, Dong Q, Li L, Zhang Z, Cai X and Pan
X: Prognostic significance of claudin-1 and cyclin B1 protein
expression in patients with hypopharyngeal squamous cell carcinoma.
Oncol Lett. 11:2995–3002. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Chai N, Xie HH, Yin JP, Sa KD, Guo Y, Wang
M, Liu J, Zhang XF, Zhang X, Yin H, et al: FOXM1 promotes
proliferation in human hepatocellular carcinoma cells by
transcriptional activation of CCNB1. Biochem Biophys Res Commun.
500:924–929. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Gu J, Liu X, Li J and He Y: MicroRNA-144
inhibits cell proliferation, migration and invasion in human
hepatocellular carcinoma by targeting CCNB1. Cancer Cell Int.
19:152019. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Fang Y, Liang X, Jiang W, Li J, Xu J and
Cai X: Cyclin b1 suppresses colorectal cancer invasion and
metastasis by regulating e-cadherin. PLoS One. 10:e01268752015.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Sit M, Aktas G, Ozer B, Kocak MZ, Erkus E,
Erkol H, Yaman S and Savli H: Mean platelet volume: An overlooked
herald of malignant thyroid nodules. Acta Clin Croat. 58:417–420.
2019.PubMed/NCBI
|
|
16
|
Wang Y, Ruan Y and Wu S: ET-1 regulates
the human umbilical vein endothelial cell cycle by adjusting the
ERβ/FOXN1 signaling pathway. Ann Transl Med. 8:14992020. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Brcic L, Heidinger M, Sever AZ, Zacharias
M, Jakopovic M, Fediuk M, Maier A, Quehenberger F, Seiwerth S and
Popper H: Prognostic value of cyclin A2 and B1 expression in lung
carcinoids. Pathology. 51:481–486. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Wang F, Chen X, Yu X and Lin Q:
Degradation of CCNB1 mediated by APC11 through UBA52 ubiquitination
promotes cell cycle progression and proliferation of non-small cell
lung cancer cells. Am J Transl Res. 11:7166–7185. 2019.PubMed/NCBI
|
|
19
|
Bao B, Yu X and Zheng W: MiR-139-5p
targeting CCNB1 modulates proliferation, migration, invasion and
cell cycle in lung adenocarcinoma. Mol Biotechnol. 64:852–860.
2022. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Leon LM, Gautier M, Allan R, Ilié M,
Nottet N, Pons N, Paquet A, Lebrigand K, Truchi M, Fassy J, et al:
Correction: The nuclear hypoxia-regulated NLUCAT1 long non-coding
RNA contributes to an aggressive phenotype in lung adenocarcinoma
through regulation of oxidative stress. Oncogene. 40:26212021.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Aran D, Camarda R, Odegaard J, Paik H,
Oskotsky B, Krings G, Goga A, Sirota M and Butte AJ: Comprehensive
analysis of normal adjacent to tumor transcriptomes. Nat Commun.
8:10772017. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Arora S, Singh P, Rahmani AH, Almatroodi
SA, Dohare R and Syed MA: Unravelling the role of miR-20b-5p,
CCNB1, HMGA2 and E2F7 in development and progression of non-small
cell lung cancer (NSCLC). Biology (Basel). 9:2012020.PubMed/NCBI
|
|
24
|
Fang L, Du WW, Awan FM, Dong J and Yang
BB: The circular RNA circ-Ccnb1 dissociates Ccnb1/Cdk1 complex
suppressing cell invasion and tumorigenesis. Cancer Lett.
459:216–226. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Zhan Q, Antinore MJ, Wang XW, Carrier F,
Smith ML, Harris CC and Fornace AJ Jr: Association with Cdc2 and
inhibition of Cdc2/Cyclin B1 kinase activity by the p53-regulated
protein Gadd45. Oncogene. 18:2892–2900. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Vairapandi M, Balliet AG, Hoffman B and
Liebermann DA: GADD45b and GADD45g are cdc2/cyclinB1 kinase
inhibitors with a role in S and G2/M cell cycle checkpoints induced
by genotoxic stress. J Cell Physiol. 192:327–338. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Li M, Shang H, Wang T, Yang SQ and Li L:
Huanglian decoction suppresses the growth of hepatocellular
carcinoma cells by reducing CCNB1 expression. World J
Gastroenterol. 27:939–958. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Ding K, Li W, Zou Z, Zou X and Wang C:
CCNB1 is a prognostic biomarker for ER+ breast cancer. Med
Hypotheses. 83:359–364. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Chen EB, Qin X, Peng K, Li Q, Tang C, Wei
YC, Yu S, Gan L and Liu TS: HnRNPR-CCNB1/CENPF axis contributes to
gastric cancer proliferation and metastasis. Aging (Albany NY).
11:7473–7491. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Moon SJ, Kim JH, Kong SH and Shin CS:
Protein expression of cyclin B1, transferrin receptor, and
fibronectin is correlated with the prognosis of adrenal cortical
carcinoma. Endocrinol Metab (Seoul). 35:132–141. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Xing Z and Wang X, Liu J, Zhang M, Feng K
and Wang X: Expression and prognostic value of CDK1, CCNA2, and
CCNB1 gene clusters in human breast cancer. J Int Med Res.
49:3000605209806472021.PubMed/NCBI
|
|
32
|
Radhakrishnan A, Nanjappa V, Raja R, Sathe
G, Chavan S, Nirujogi RS, Patil AH, Solanki H, Renuse S,
Sahasrabuddhe NA, et al: Dysregulation of splicing proteins in head
and neck squamous cell carcinoma. Cancer Biol Ther. 17:219–229.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Zhuang L, Yang Z and Meng Z: Upregulation
of BUB1B, CCNB1, CDC7, CDC20, and MCM3 in tumor tissues predicted
worse overall survival and disease-free survival in hepatocellular
carcinoma patients. Biomed Res Int. 2018:78973462018. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Fu S, Jin L, Gong T, Pan S, Zheng S, Zhang
X, Yang T, Sun Y, Wang Y, Guo J, et al: Effect of sinomenine
hydrochloride on radiosensitivity of esophageal squamous cell
carcinoma cells. Oncol Rep. 39:1601–1608. 2018.PubMed/NCBI
|
|
35
|
Chae SW, Sohn JH, Kim DH, Choi YJ, Park
YL, Kim K, Cho YH, Pyo JS and Kim JH: Overexpressions of cyclin B1,
cdc2, p16 and p53 in human breast cancer: The clinicopathologic
correlations and prognostic implications. Yonsei Med J. 52:445–453.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Zhou L, Li J, Zhao YP, Cui QC, Zhou WX,
Guo JC, You L, Wu WM and Zhang TP: The prognostic value of cyclin
B1 in pancreatic cancer. Med Oncol. 31:1072014. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Woldu SL, Hutchinson RC, Krabbe LM, Sanli
O and Margulis V: The Rho GTPase signalling pathway in urothelial
carcinoma. Nat Rev Urol. 15:83–91. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Lawson CD and Ridley AJ: Rho GTPase
signaling complexes in cell migration and invasion. J Cell Biol.
217:447–457. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Zhou B, Wang GZ, Wen ZS, Zhou YC, Huang
YC, Chen Y and Zhou GB: Somatic mutations and splicing variants of
focal adhesion kinase in non-small cell lung cancer. J Natl Cancer
Inst. 110:195–204. 2018. View Article : Google Scholar
|
|
40
|
Walker S, Foster F, Wood A, Owens T,
Brennan K, Streuli CH and Gilmore AP: Oncogenic activation of FAK
drives apoptosis suppression in a 3D-culture model of breast cancer
initiation. Oncotarget. 7:70336–70352. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Brami-Cherrier K, Gervasi N, Arsenieva D,
Walkiewicz K, Boutterin MC, Ortega A, Leonard PG, Seantier B, Gasmi
L, Bouceba T, et al: FAK dimerization controls its kinase-dependent
functions at focal adhesions. EMBO J. 33:356–370. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Shen Y, Ma Y, Gao M, Lai Y, Wang G, Yu Q,
Cui FZ and Liu X: Integrins-FAK-Rho GTPases pathway in endothelial
cells sense and response to surface wettability of plasma
nanocoatings. ACS Appl Mater Interfaces. 5:5112–5121. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Selamat SA, Chung BS, Girard L, Zhang W,
Zhang Y, Campan M, Siegmund KD, Koss MN, Hagen JA, Lam WL, et al:
Genome-scale analysis of DNA methylation in lung adenocarcinoma and
integration with mRNA expression. Genome Res. 22:1197–1211. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Sanchez-Carbayo M, Socci ND, Lozano J,
Saint F and Cordon-Cardo C: Defining molecular profiles of poor
outcome in patients with invasive bladder cancer using
oligonucleotide microarrays. J Clin Oncol. 24:778–789. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Curtis C, Shah SP, Chin SF, Turashvili G,
Rueda OM, Dunning MJ, Speed D, Lynch AG, Samarajiwa S, Yuan Y, et
al: The genomic and transcriptomic architecture of 2,000 breast
tumours reveals novel subgroups. Nature. 486:346–352. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Fortier AM, Asselin E and Cadrin M:
Keratin 8 and 18 loss in epithelial cancer cells increases
collective cell migration and cisplatin sensitivity through
claudin1 up-regulation. J Biol Chem. 288:11555–11571. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Galarneau L, Loranger A, Gilbert S and
Marceau N: Keratins modulate hepatic cell adhesion, size and G1/S
transition. Exp Cell Res. 313:179–194. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Wang Y, He QY, Tsao SW, Cheung YH, Wong A
and Chiu JF: Cytokeratin 8 silencing in human nasopharyngeal
carcinoma cells leads to cisplatin sensitization. Cancer Lett.
265:188–196. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Mulay SR, Honarpisheh MM, Foresto-Neto O,
Shi C, Desai J, Zhao ZB, Marschner JA, Popper B, Buhl EM, Boor P,
et al: Mitochondria permeability transition versus necroptosis in
oxalate-induced AKI. J Am Soc Nephrol. 30:1857–1869. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Nakagawa T, Shimizu S, Watanabe T,
Yamaguchi O, Otsu K, Yamagata H, Inohara H, Kubo T and Tsujimoto Y:
Cyclophilin D-dependent mitochondrial permeability transition
regulates some necrotic but not apoptotic cell death. Nature.
434:652–658. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Yang L, Cui Y, Sun X and Wang Y:
Overexpression of TICRR and PPIF confer poor prognosis in
endometrial cancer identified by gene co-expression network
analysis. Aging (Albany NY). 13:4564–4589. 2021. View Article : Google Scholar : PubMed/NCBI
|
